Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: What do we know about risks and benefits?

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 4, 2012, Pages 393-402

  Masotti, Luca ^a   Godoy, Daniel Agustin ^b   Napoli, Mario Di ^c   Rabinstein, Alejandro A ^d   Paciaroni, Maurizio ^e   Ageno, Walter ^f  

^a Cecina Hospital   (Italy)

^b Neurocritical Care Unit Sanatorio Pasteur   (Argentina)

^c SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

deep vein thrombosis; intracerebral hemorrhage; low molecular weight heparin; prophylaxis; pulmonary embolism; therapy; unfractioned heparin

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; CERTOPARIN; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHYTOMENADIONE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIVAROXABAN;

ADVERSE OUTCOME; AGING; ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL PRACTICE; COMPRESSION GARMENT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HEMATOMA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMOBILIZATION; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LOW DRUG DOSE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROSURGERY; OBESITY; OBSERVATIONAL STUDY; PARALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FEMALE; HEMATOMA, EPIDURAL, CRANIAL; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84863445958     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612441055     Document Type: Review

References (78)

1. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet. 2009;373(9675):1632-1644.
2. Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108-2129.
3. Van Asch C, Luitse MA, Rinkel GE, van der Tweel I, Klijn CM. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167-176.
4. Qureshi AI, Suri MFK, Nasar A, et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke. 2007;38(7):2180-2184. (Pubitemid 47012287)
5. Sutherland GR, Auer RN. Primary intracerebral hemorrhage. J Clin Neurosci. 2006;13(5):511-517. (Pubitemid 43850282)
6. Qureshi AI, Thurim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450-1460. (Pubitemid 32402103)
7. Mayer SA, Rincon F. Treatment of intracerebral hemorrhage. Lancet Neurol. 2005;4(10):662-672.
8. Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66(8):1175-1181. (Pubitemid 43739699)
9. Steiner T, Bösel J. Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke. 2010;41(2):402-409.
10. Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P, CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke. 2008;39(11):2293-2296.
11. Rodriguez-Luna D, Rubiera M, Ribo M, et al. Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage. Neurology. 2011;77(17):1599-1604.
12. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1999;28(12):2370-2375.
13. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35(6):1364-1367. (Pubitemid 38697459)
14. Rincon F, Mayer SA. Novel therapies for intracerebral hemorrhage. Curr Opin Crit Care. 2004;10(2):94-100. (Pubitemid 38519715)
15. Badjatia N, Rosand J. Intracerebral hemorrhage. Neurologist. 2005;11(6):311-324. (Pubitemid 41683153)
16. Fewel ME, Thompson G, Hoff JT. Spontaneous intracerebral hemorrhage: a review. Neurosurg Focus. 2003;15(4):1-16.
17. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63(6):1059-1064. (Pubitemid 39287915)
18. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke. 2003;34(1):224-229. (Pubitemid 36070827)
19. Rincon F, Mayer SA. Novel therapies for intracerebral hemorrhage. Curr Opin Crit Care. 2004;10(2):94-100. (Pubitemid 38519715)
20. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010;363(3):266-274.
21. Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J Neurosurg. 2011;114(1):40-46.
22. Browd SR, Ragel BT, Davis GE, Scott AM, Skalabrin EJ, Couldwell WT. Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus. 2004;17(4):E1.
23. Danish SF, Burnett MG, Stein SC. Prophylaxis for deep venous thrombosis in patients with craniotomies: a review. Neurosurg Focus. 2004;17(4):E2.
24. Hamilton MG, Hull RD, Pineo GF. Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery. 1994;34(2):280-296. Discussion 296.
25. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil. 2003;82(5):384-389.
26. Raslan AM, Fields JD, Bhardwaj A. Prophylaxis for venous thrombo-embolism in neurocritical care: a critical appraisal. Neurocrit Care. 2010;12(2):297-309.
27. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol. 2005;96(12):1731-1733. (Pubitemid 41790400)
28. Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc. 1997;72(4):297-300. (Pubitemid 28194192)
29. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke. 2001;32(1):262-267. (Pubitemid 32063854)
30. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P; American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl):630S-669S. (Pubitemid 351892974)
31. Tonarelli SB, Hart RG. Prevention and treatment of venous thromboembolism in patients with acute intracerebral hemorrhage. Semin Cerebrovasc Dis Stroke. 2005;5(3):189-193.
32. Andrè C, De Freitas GR, FukujimaMM. Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles. Eur J Neurol. 2007;14(1):21-32. (Pubitemid 46088032)
33. Goldstein JN, Fazen LE, Wendell L, et al. Risk of thromboembolism following intracerebral hemorrhage. Neurocritic Care. 2009;10(1):28-34.
34. Kim KS, Brophy GM. Symptomatc venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit Care. 2009;11(1):28-33.
35. Kawase K, Okazaki S, Toyoda K, et al. Sex difference in the prevalence of deep-vein thrombosis in Japanese patients with acute intracerebral hemorrhage. Cerebrovasc Dis. 2009;27(4):313-319.
36. Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep vein thrombosis after acute intracerebral hemorrhage. J Neurol Sci. 2008;272(1-2):83-86.
37. Masotti L, Di Napoli M, Godoy D, et al. The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. Int J Stroke. 2011;6(3):228-240.
38. Dentali F, Marchesi C, Pierfranceschi MG, et al. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost. 2011;106(3):429-438.
39. Robinson MT, Rabinstein AA, Meschia JF, Freeman WD. Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system. Stroke. 2010;41(7):1459-1463.
40. Kelly J, Hunt BJ, Lewis RR, Rudd A. Anticoagulation or inferior vena cava filter placement for patients with primary intracerebral hemorrhage developing venous thromboembolism? Stroke. 2003;34(12):2999-3005. (Pubitemid 37517784)
41. Hamilton MG, Yee WH, Hull RD, Ghali WA. Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis. Neurosurgery. 2011;68(3):571-581.
42. Collen JF, Jackson JL, Shorr AF, Moores LK. Prevention of venous thromboembolism in neurosurgery: a meta analysis. Chest. 2008;134(2):237-249.
43. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med. 2000;160(15):2327-2332.
44. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 suppl):381S-453S. (Pubitemid 351894916)
45. Kurtoglu M, Yanar H, Bilsel Y, et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg. 2004;28(8):807-811. (Pubitemid 39315399)
46. Depew AJ, Hu CK, Nguyen AC, Driessen N. Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review. Am Surg. 2008;74(10):906-911.
47. Norwood SH, Beme JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma. 2008;65(5):1021-1026.
48. Norwood SH, McAuley CE, Berne JD, et al. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137(6):696-701.
49. Cupitt JM. Prophylaxis against thromboembolism in patients with traumatic brain injury: a survey of UK practice. Anaesthesia. 2001;56(8):780-785. (Pubitemid 32755148)
50. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341(11):793-800. (Pubitemid 29420474)
51. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomised control trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110(7):874-879. (Pubitemid 39096017)
52. Cohen AT, Davidson BL, Gallus AS, et al ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332(7537):325-329.
53. Sherman DG, Albers GW, Bladin C, et al PREVAIL Investigators. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet. 2007;369(9570):1347-1355. (Pubitemid 46621092)
54. Cohen AT, Spiro TE, Büller HR, et al. Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis. 2011;31(4):407-416.
55. Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, et al ADOPT Trial Investigators. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med. 2011;365(23):2167-2177.
56. Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PAG. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev. 2010;(8):CD001922.
57. CLOTS Trials Collaboration, Dennis M, Sandercock PA, Reid J, Graham C, Murray G, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomized controlled trial. Lancet. 2009;373(9679):1958-1965.
58. CLOTS (Clots in Legs or Stockings after Stroke) Trial Collaboration. Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial. Ann Intern Med. 2010;153(9):553-562.
59. Lacut K, Bressollette L, Le Gal G, et al.; VICTORIAh (Venous Intermittent Compression and Thrombosis Occurrence Related to Intra-cerebral Acute hemorrhage) Investigators. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology. 2005;65(6):865-869.
60. Dickmann U, Voth E, Schicha H, Henze T, Prange H, Emrich D. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr. 1988;66(23):1182-1183. (Pubitemid 19019454)
61. Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54(5):466-467.
62. Kleindienst A, Harvey HB, Mater E, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien). 2003;145(12):1085-1091. (Pubitemid 38091023)
63. Harvey RL, Lovell LL, Belanger N, Roth EJ. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort study. Arch Phys Med Rehabil. 2004;85(7):1070-1075. (Pubitemid 38962362)
64. Tetri S, Hakala J, Juvela S, et al. Safety of low dose subcutaneous enoxaparin for the prevention of venous thromboembolismafter primary intracerebral haemorrhage. Thromb Res. 2008;123(2):206-212.
65. Wasay M, Khan S, Zaki KS, et al. A non-randomized study of safety and efficacy of heparin for DVT prophylaxis in intracerebral hemorrhage. J Pak Med Assoc. 2008;58(7):362-364. (Pubitemid 351955154)
66. Kiphuth IC, Staykov D, Köhrmann M, et al. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage: a safety analysis. Cerebrovasc Dis. 2009;27(2):146-150.
67. Orken DN, Kenangil G, Ozkurt H, et al. Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist. 2009;15(6):329-331.
68. Wu TC, Kasam M, Harun N, et al. Pharmacological deep vein thrombosis prohylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension. Stroke. 2011;42(3):705-709.
69. Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost. 2011;9(5):893-898.
70. Intercollegiate Stroke Working Party. National clinical guideline for stroke. 2nd ed. www.rcplondon.ac.uk/resources/stroke-guidelines. Accessed 2004.
71. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial hemorrhage-part I: spontaneous intracerebral hemorrhage. The European Stroke Initiative Writing Committee and the writing committee for the EUSI Executive committee. Cerebrovasc Dis. 2006;22(4):294-316.
72. Ageno W, Agnelli G, Checchia G, et al. Prevention of venous thromboembolism in immobilizer neurological patients: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res. 2009;124(5):e26-e31.
73. Intercollegiate Stroke Working Party. National clinical guideline for stroke. 3rd ed. www.rcplondon.ac.uk/resources/stroke-guidelines. Accessed 2008.
74. National Institute for Health and Clinical Excellence CG92. Venous thromboembolism reducing the risk: NICE guidelines. www.nice.org.uk/guidance/ CG92.
75. National Institute for Health and Clinical Excellence CG68. Diagnosis and initial management of acute stroke and transient ischaemic attack. www.nice.org.uk/CG68.
76. National Stroke Foundaton. Clinical guidelines for Stroke management 2010. www.strokefoundation.com.au/clinical-guidelines
77. Qaseem A, Chou R, Humphrey LL, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011; 155(9):625-632.
78. Lansberg MG, O'Donnell MJ, Khatri P et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl):e601S-e636S.